STUB1 and Stroke: The patients with loss of follow‐up (n = 114), history of malignancies (n = 94), TIA diagnosis (n = 679), recurrent stroke at 3 months (n = 612), and CHIP driven by other genes (n = 218) were excluded (Figure 1).